Takahiro Nagayama

This inventor holds 11 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 5 EPO patents. Top assignees: Nippon Chemical Industrial Co., Ltd., Sanford Burnham Prebys Medical Discovery Institute, Daiichi Sankyo Company, Limited. Active years: 2000-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takahiro Nagayama. Retrieved from https://idiyas.com/inventor/takahiro-nagayama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 1)

% Patents Active = 45.5

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 39(Granted Patents)

Company Filing History:

3 out of 163

Nippon Chemical Industrial Co., Ltd.

patents

3 out of 99

Sanford Burnham Prebys Medical Discovery Institute

patents

2 out of 463

Daiichi Sankyo Company, Limited

patents

4. 2 out of 2,208

Fuji Jukogyo Kabushiki Kaisha

patents

5. 1 out of 4

Toho Ganryo Kogyo Co., Ltd.

patents

6. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2024

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12071413 - Azole derivatives as apelin receptor agonist (2024-08-27),

2. 11155525 - Azole derivatives as apelin receptor agonist (2021-10-26),

3. 10947289 - Glyco-modified atrial natriuretic peptide (2021-03-16),

4. 10626096 - Azole derivatives as apelin receptor agonist (2020-04-21),

5. 9279436 - Joint structure for fiber reinforced resin and metal (2016-03-08),

6. 8808822 - Joint structure for fiber reinforced resin and metal, and joining method for fiber reinforced resin and metal (2014-08-19),

7. 8158790 - Cyclic amine compound (2012-04-17),

8. 7045561 - Modified red phosphorus, method of producing the same, decolorized red phosphorus composition and flame-retardant polymer composition (2006-05-16),

9. 6572834 - Aqueous zinc nitrite solution and method for preparing the same (2003-06-03),

10. 6458219 - Metal surface-treating method (2002-10-01),

11. 6139616 - Rust-preventive pigment composition and rust-preventive paints (2000-10-31),

Title: Takahiro Nagayama: Innovator in Pharmaceutical Chemistry

Introduction

Takahiro Nagayama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for treating various diseases. With a total of 11 patents to his name, his work has the potential to impact the medical community significantly.

Latest Patents

One of his latest patents involves azole derivatives as apelin receptor agonists. This invention relates to a novel azole derivative that can be used in methods for treating cardiovascular diseases, diabetic diseases, renal diseases, hypertension, and arteriosclerosis. The patent provides a compound represented by a specific formula, which includes various groups that enhance its pharmacological properties.

Career Highlights

Throughout his career, Takahiro has worked with notable companies such as Nippon Chemical Industrial Co., Ltd. and Sanford Burnham Prebys Medical Discovery Institute. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical sector.

Collaborations

Takahiro has collaborated with esteemed colleagues, including Yutaka Kinose and Takuya Ikeda. These partnerships have fostered an environment of innovation and creativity, leading to the development of impactful inventions.

Conclusion

Takahiro Nagayama's work exemplifies the spirit of innovation in pharmaceutical chemistry. His contributions through patents and collaborations continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.